sulindac nonsteroidal antiinflammatory drug nsaid arylalkanoic acid class marketed clinoril imbaral confused mebaral another name drug name derived sulfinyl indene acetic acid patented approved medical use like nsaids useful treatment acute chronic inflammatory conditions sulindac prodrug derived sulfinylindene converted body active nsaid specifically agent converted liver enzymes sulfide excreted bile reabsorbed intestine thought help maintain constant blood levels reduced gastrointestinal side effects studies shown sulindac relatively less irritating stomach nsaids except drugs inhibitor exact mechanism nsaid properties unknown thought act enzymes inhibiting prostaglandin synthesis usual dosage milligrams twice per day food used persons history major allergic reactions urticaria anaphylaxis aspirin nsaids used caution persons preexisting peptic ulcer disease sulindac much likely nsaids cause damage liver pancreas though less likely cause kidney damage nsaids sulindac seems property independent coxinhibition reducing growth polyps precancerous lesions colon especially association familial adenomatous polyposis may anticancer october us food drug administration fda required drug label updated nonsteroidal antiinflammatory medications describe risk kidney problems unborn babies result low amniotic recommend avoiding nsaids pregnant women weeks later september federal jury new hampshire awarded million karen bartlett woman developed syndrometoxic epidermal necrolysis result taking generic brand sulindac manufactured mutual pharmaceuticals shoulder pain ms bartlett sustained severe injuries including loss surface skin permanent nearblindness case appealed united states supreme court main issue whether federal law preempts ms bartletts june supreme court ruled favor mutual pharmaceuticals throwing earlier million jury rxn pfluorobenzyl chloride anion diethylmethyl malonate gives intermediate diester saponification subsequent decarboxylation leads alternatively formed perkin reaction pfluorobenzaldehyde propionic anhydride presence naoac followed catalytic hydrogenation olefinic bond using palladium carbon catalyst polyphosphoric acid ppa cyclization leads reformatsky reaction zinc amalgam bromoacetic ester leads carbinol dehydrated tosic acid indene alternatively step performed knoevenagel condensation cyanoacetic acid decarboxylated active methylene group condensed pmethylthiobenzaldehyde using sodium methoxide catalyst saponified give z turn oxidized sodium metaperiodate sulfoxide antiinflammatory agent sulindac httpsenwikipediaorgwikisulindac